Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Journal

Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 24 1 2019
medline: 24 1 2019
entrez: 24 1 2019
Statut: ppublish

Résumé

In the original publication of the article, two sentences in the "Results" section were published incorrectly. The corrected texts are provided below.

Identifiants

DOI: 10.1007/s10157-019-01694-w PMID: 30673934 PMC: PMC6828206
pubmed: 30673934
doi: 10.1007/s10157-019-01694-w
pii: 10.1007/s10157-019-01694-w
pmc: PMC6828206
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

435

Commentaires et corrections

Type : ErratumFor

Auteurs

Tetsuhiro Tanaka (T)

Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Masaomi Nangaku (M)

Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Enyu Imai (E)

Internal Medicine of Nakayamadera Imai Clinic, Takarazuka, Hyogo, Japan.

Yoshiharu Tsubakihara (Y)

Graduate School of Health Care Sciences, Jikei Institute, Yodogawa-ku, Osaka, Japan.

Masatoshi Kamai (M)

Pharmacovigilance Department, Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo, Japan.

Michihito Wada (M)

Medical Affairs Department, Kyowa Hakko Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.

Shinji Asada (S)

Medical Affairs Department, Kyowa Hakko Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. shinji.asada@kyowa-kirin.co.jp.

Tadao Akizawa (T)

Showa University, Shinagawa-ku, Tokyo, Japan.

Classifications MeSH